Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15079004rdf:typepubmed:Citationlld:pubmed
pubmed-article:15079004lifeskim:mentionsumls-concept:C0038454lld:lifeskim
pubmed-article:15079004lifeskim:mentionsumls-concept:C0004057lld:lifeskim
pubmed-article:15079004lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:15079004lifeskim:mentionsumls-concept:C0007785lld:lifeskim
pubmed-article:15079004lifeskim:mentionsumls-concept:C1708528lld:lifeskim
pubmed-article:15079004lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:15079004lifeskim:mentionsumls-concept:C0077126lld:lifeskim
pubmed-article:15079004pubmed:issue7lld:pubmed
pubmed-article:15079004pubmed:dateCreated2004-4-13lld:pubmed
pubmed-article:15079004pubmed:abstractTextTriflusal is an antiplatelet agent that has shown clinical advantages when compared with aspirin in the secondary prevention of vascular events. TAPIRSS (Triflusal versus Aspirin for Prevention of Infarction: a Randomized Stroke Study) explored the efficacy and safety of triflusal in the secondary prevention of stroke in a Latin American homogeneous population with the ultimate aim of preparing for a larger trial in the same setting.lld:pubmed
pubmed-article:15079004pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15079004pubmed:languageenglld:pubmed
pubmed-article:15079004pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15079004pubmed:citationSubsetAIMlld:pubmed
pubmed-article:15079004pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15079004pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15079004pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15079004pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15079004pubmed:statusMEDLINElld:pubmed
pubmed-article:15079004pubmed:monthAprlld:pubmed
pubmed-article:15079004pubmed:issn1526-632Xlld:pubmed
pubmed-article:15079004pubmed:authorpubmed-author:VilaJJlld:pubmed
pubmed-article:15079004pubmed:authorpubmed-author:ReichEElld:pubmed
pubmed-article:15079004pubmed:authorpubmed-author:FerrariJJlld:pubmed
pubmed-article:15079004pubmed:authorpubmed-author:CulebrasAAlld:pubmed
pubmed-article:15079004pubmed:authorpubmed-author:FamulariAAlld:pubmed
pubmed-article:15079004pubmed:authorpubmed-author:DomínguezRRlld:pubmed
pubmed-article:15079004pubmed:authorpubmed-author:ReyRRlld:pubmed
pubmed-article:15079004pubmed:authorpubmed-author:GoriHHlld:pubmed
pubmed-article:15079004pubmed:authorpubmed-author:AbiusiGGlld:pubmed
pubmed-article:15079004pubmed:authorpubmed-author:Rotta-Escalan...lld:pubmed
pubmed-article:15079004pubmed:authorpubmed-author:Bauso-Tossell...lld:pubmed
pubmed-article:15079004pubmed:authorpubmed-author:TAPIRSS...lld:pubmed
pubmed-article:15079004pubmed:issnTypeElectroniclld:pubmed
pubmed-article:15079004pubmed:day13lld:pubmed
pubmed-article:15079004pubmed:volume62lld:pubmed
pubmed-article:15079004pubmed:ownerNLMlld:pubmed
pubmed-article:15079004pubmed:authorsCompleteYlld:pubmed
pubmed-article:15079004pubmed:pagination1073-80lld:pubmed
pubmed-article:15079004pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:15079004pubmed:meshHeadingpubmed-meshheading:15079004...lld:pubmed
pubmed-article:15079004pubmed:meshHeadingpubmed-meshheading:15079004...lld:pubmed
pubmed-article:15079004pubmed:meshHeadingpubmed-meshheading:15079004...lld:pubmed
pubmed-article:15079004pubmed:meshHeadingpubmed-meshheading:15079004...lld:pubmed
pubmed-article:15079004pubmed:meshHeadingpubmed-meshheading:15079004...lld:pubmed
pubmed-article:15079004pubmed:meshHeadingpubmed-meshheading:15079004...lld:pubmed
pubmed-article:15079004pubmed:meshHeadingpubmed-meshheading:15079004...lld:pubmed
pubmed-article:15079004pubmed:meshHeadingpubmed-meshheading:15079004...lld:pubmed
pubmed-article:15079004pubmed:meshHeadingpubmed-meshheading:15079004...lld:pubmed
pubmed-article:15079004pubmed:meshHeadingpubmed-meshheading:15079004...lld:pubmed
pubmed-article:15079004pubmed:meshHeadingpubmed-meshheading:15079004...lld:pubmed
pubmed-article:15079004pubmed:meshHeadingpubmed-meshheading:15079004...lld:pubmed
pubmed-article:15079004pubmed:meshHeadingpubmed-meshheading:15079004...lld:pubmed
pubmed-article:15079004pubmed:meshHeadingpubmed-meshheading:15079004...lld:pubmed
pubmed-article:15079004pubmed:meshHeadingpubmed-meshheading:15079004...lld:pubmed
pubmed-article:15079004pubmed:meshHeadingpubmed-meshheading:15079004...lld:pubmed
pubmed-article:15079004pubmed:meshHeadingpubmed-meshheading:15079004...lld:pubmed
pubmed-article:15079004pubmed:meshHeadingpubmed-meshheading:15079004...lld:pubmed
pubmed-article:15079004pubmed:year2004lld:pubmed
pubmed-article:15079004pubmed:articleTitleTriflusal vs aspirin for prevention of cerebral infarction: a randomized stroke study.lld:pubmed
pubmed-article:15079004pubmed:affiliationDepartment of Neurology, Upstate Medical University, Syracuse, NY 13210, USA. aculebras@aol.comlld:pubmed
pubmed-article:15079004pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15079004pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:15079004pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:15079004pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:15079004pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:15079004pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15079004lld:pubmed